What is the P/E ratio of Supriya Pharmaceuticals?

The latest standalone P/E ratio of Supriya Pharmaceuticals as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Supriya Pharmaceuticals?

The latest standalone P/B ratio of Supriya Pharmaceuticals as of 01-Jan-1970 is 1.19.

What is the 52-week high and low of Supriya Pharmaceuticals?

The 52-week high of Supriya Pharmaceuticals is Rs. 0.00 and the 52-week low is Rs. 0.00.

Supriya Pharmaceuticals Ltd - Stock Valuation and Financial Performance

Name: Supriya Pharmaceuticals
Brand: Supriya Pharmaceuticals

BSE: 524784 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Supriya Pharma

Based on:

Data

M-Cap below 100cr DeciZen not available

Supriya Pharmaceuticals stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

6 Cr.

52-wk low:

52-wk high:

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Supriya Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Jun'97	Jun'98	Sep'99	Sep'02	Sep'03	Sep'04	TTM
ROCE % ⓘ	-272.9%	-204.8%	218%	99.5%	24.5%	-5.4%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	22.4	22.9	67	13.6	7.5	3.1	0
Sales YoY Gr.	-	2.2%	192.8%	-79.7%	-44.9%	-59.3%	-
Adj EPS ⓘ	-12.6	-5.5	2	4.4	1.8	-0.7	-0.1
YoY Gr.	-	NA	NA	121%	-59.3%	-137.8%	-
BVPS (₹) ⓘ	1.7	-3.5	-0.7	6.7	9	8.5	8.7
Adj Net Profit ⓘ	-6.2	-2.7	1	2.2	0.9	-0.3	0
Cash Flow from Ops. ⓘ	0	0.5	0.4	4.7	0	-0.6	-
Debt/CF from Ops. ⓘ	0	3.2	2.4	0	16.6	-2.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-32.8%	-64.3%	-59.3%
Adj EPS ⓘ	NA	NA	-169.8%	-137.8%
BVPSⓘ	NA	37.6%	NA	-5.7%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Jun'97	Jun'98	Sep'99	Sep'02	Sep'03	Sep'04	TTM
Return on Equity % ⓘ	-451.4	-5198.9	-188.5	125.8	21.9	-7.6	-1.4
Op. Profit Mgn % ⓘ	-25.9	-29.1	1.5	12.7	14.7	-55.2	NAN
Net Profit Mgn % ⓘ	-27.6	-11.8	1.5	16	11.8	-11	-INF
Debt to Equity ⓘ	0.8	-0.9	-2.6	0	0.1	0.3	-
Working Cap Days ⓘ	0	162	60	276	320	751	0
Cash Conv. Cycle ⓘ	0	89	33	94	-1	152	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Supriya Pharmaceuticals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0.1	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	8.7	-
Reserves (₹ Cr.) ⓘ	-1	-
P/BV ⓘ	1.19	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	0.95 / 19.00
Market Cap (₹ Cr.)	6
Equity (₹ Cr.)	5.9
Face Value (₹)	10
Industry PE ⓘ	47.6

Management X-Ray of Supriya Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Supriya Pharma

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Supriya Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Jun'97	Jun'98	Sep'99	Sep'02	Sep'03	Sep'04
Sales	22.38	22.88	83.74	13.62	7.51	3.06
Operating Expenses ⓘ	28.18	29.54	82.47	11.91	6.41	4.77
Manufacturing Costs	0.80	1.07	3.48	1.51	1.91	1.02
Material Costs	25.38	27.54	77.46	9.47	3.48	2.84
Employee Cost	0.39	0.45	0.65	0.50	0.64	0.45
Other Costs ⓘ	1.61	0.50	0.88	0.42	0.37	0.46
Operating Profit ⓘ	-5.80	-6.66	1.27	1.72	1.10	-1.72
Operating Profit Margin (%)	-25.9%	-29.1%	1.5%	12.6%	14.7%	-56.2%
Other Income ⓘ	0.68	4.98	0.68	0.98	0.41	1.79
Interest ⓘ	0.74	0.52	0.19	0.19	0.27	0.06
Depreciation ⓘ	0.30	0.43	0.53	0.34	0.35	0.36
Exceptional Items ⓘ	0	0	0	0	0	0
Profit Before Tax ⓘ	-6.16	-2.63	1.24	2.17	0.88	-0.35
Tax ⓘ	0.01	0	0.01	0	0	0
Profit After Tax	-6.18	-2.63	1.23	2.17	0.88	-0.35
PAT Margin (%)	-27.6%	-11.5%	1.5%	15.9%	11.8%	-11.6%
Adjusted EPS (₹)	-12.6	-5.4	2.5	4.4	1.8	-0.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Jun'97	Jun'98	Sep'99	Sep'02	Sep'03	Sep'04
Equity and Liabilities
Shareholders Fund	1.37	-1.27	-0.04	3.49	4.57	4.25
Share Capital ⓘ	4.92	4.92	4.92	4.92	4.92	4.92
Reserves ⓘ	-3.55	-6.19	-4.96	-1.43	-0.35	-0.67
Minority Interest	0	0	0	0	0	0
Debt	0.71	1.47	1.08	0.10	0.61	1.26
Long Term Debt	0.71	1.47	1.08	0.10	0.61	1.26
Short Term Debt	0	0	0	0	0	0
Trade Payables	3.04	3.49	3.34	4.29	3.72	3.73
Others Liabilities ⓘ	9.81	12.24	13.97	1.90	0.42	-0.33
Total Liabilities ⓘ	14.92	15.93	18.36	9.79	9.31	8.90
Fixed Assets
Gross Block	4.24	4.60	5.03	5.52	6.05	5.89
Accumulated Depreciation	1.32	1.75	2.28	3.18	3.53	3.66
Net Fixed Assetsⓘ	2.92	2.85	2.74	2.34	2.52	2.24
CWIP ⓘ	0	0	0	0	0.07	0
Investmentsⓘ	0	0	0	0	0	0
Inventories	5.93	9.12	11.79	3.49	3.46	2.04
Trade Receivables	2.23	1.44	0.67	1.82	1.05	1.25
Cash Equivalents	0.17	0.08	0.10	0.06	0.01	0
Others Assetsⓘ	3.67	2.45	3.06	2.07	2.21	3.37
Total Assets ⓘ	14.92	15.93	18.36	9.79	9.31	8.90

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Jun'98	Sep'99	Sep'02	Sep'03	Sep'04
Cash Flow From Operating Activity ⓘ	0.46	0.46	4.71	0.04	-0.55
PBT ⓘ	1.23	1.23	2.17	0.88	-0.35
Adjustment ⓘ	0.60	0.60	0.40	0.41	0.52
Changes in Working Capital ⓘ	-1.37	-1.37	2.15	-1.26	-0.71
Tax Paid ⓘ	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	-0.43	-0.43	-0.48	-0.60	-0.11
Capex	-0.43	-0.43	-0.48	-0.53	-0.11
Net Investments	0	0	0	0	0
Others ⓘ	0	0	0	-0.07	0
Cash Flow From Financing Activityⓘ	0	0	-4.23	0.51	0.65
Net Proceeds from Shares ⓘ	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	0	0	-4.23	0.51	0.65
Net Cash Flow ⓘ	0.03	0.03	0	-0.06	-0.01

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Jun'97	Jun'98	Sep'99	Sep'02	Sep'03	Sep'04
Ratios
ROE (%)	-723.84	N/A	N/A	150	22.79	-8.21
ROCE (%)	-347.87	N/A	N/A	115.81	27.36	-5.55
Asset Turnover Ratio	1.69	1.74	4.88	1.05	0.82	0.35
PAT to CFO Conversion(x)	N/A	N/A	0.37	2.17	0.05	N/A
Working Capital Days
Receivable Days	32	25	5	31	67	131
Inventory Days	86	102	46	189	161	313
Payable Days	44	43	16	147	420	479

Supriya Pharmaceuticals Ltd Stock News

Supriya Pharmaceuticals Ltd FAQs

What is the share price of Supriya Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Supriya Pharma on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Supriya Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Supriya Pharma stood at ₹6.04.